RCC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.749200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.161200E-01
Normal-vs-Stage2
6.112400E-01
Normal-vs-Stage3
4.041600E-01
Normal-vs-Stage4
8.723600E-01
Stage1-vs-Stage2
2.257800E-01
Stage1-vs-Stage3
7.106600E-01
Stage1-vs-Stage4
6.181800E-01
Stage2-vs-Stage3
1.619420E-01
Stage2-vs-Stage4
7.179200E-01
Stage3-vs-Stage4
4.406200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.680000E-01
Normal-vs-AfricanAmerican
5.199200E-01
Normal-vs-Asian
9.160200E-01
Caucasian-vs-AfricanAmerican
4.784000E-01
Caucasian-vs-Asian
6.649200E-01
AfricanAmerican-vs-Asian
3.100000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.576400E-01
Normal-vs-Female
7.884600E-01
Male-vs-Female
9.989000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.668800E-01
Normal-vs-Age(41-60Yrs)
5.447000E-01
Normal-vs-Age(61-80Yrs)
9.285400E-01
Normal-vs-Age(81-100Yrs)
7.449200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.679200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.171800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.213400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.736100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.460600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.842600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.456000E-01
Normal-vs-Daily Drinker
4.906000E-01
Normal-vs-Weekly Drinker
8.063200E-01
Normal-vs-Occasional Drinker
5.781600E-01
Normal-vs-Social Drinker
9.672400E-01
Non Drinker-vs-Daily Drinker
1.445040E-01
Non Drinker-vs-Weekly Drinker
6.674400E-01
Non Drinker-vs-Occasional Drinker
3.374600E-01
Non Drinker-vs-Social Drinker
8.391600E-01
Daily Drinker-vs-Weekly Drinker
6.373600E-01
Daily Drinker-vs-Occasional Drinker
6.327400E-01
Daily Drinker-vs-Social Drinker
1.572750E-01
Weekly Drinker-vs-Occasional Drinker
9.017200E-01
Weekly Drinker-vs-Social Drinker
5.922800E-01
Occasional Drinker-vs-Social Drinker
2.837200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.859000E-01
Normal-vs-Grade 2
6.794800E-01
Normal-vs-Grade 3
6.871800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.172000E-04
Grade 1-vs-Grade 3
4.962200E-04
Grade 1-vs-Grade 4
5.859000E-01
Grade 2-vs-Grade 3
7.524200E-01
Grade 2-vs-Grade 4
6.794800E-01
Grade 3-vs-Grade 4
6.871800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.051800E-01
Normal-vs-NonDiabetic
7.191200E-01
Diabetic-vs-NonDiabetic
4.246000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.651200E-01
Normal-vs-NoPancreatitis
7.765400E-01
Pancreatitis-vs-NoPancreatitis
2.446200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.549600E-01
Normal-vs-N1
6.476400E-01
N0-vs-N1
6.854300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.566850E-01
Normal-vs-TP53-NonMutant
6.460400E-01
TP53-Mutant-vs-TP53-NonMutant
2.5852997520559E-10
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
